BusinessGerman pharma firms seek COVID drugs fundingTo view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 videoBusinessTabea Mergenthaler05/19/2021May 19, 2021Thanks to generous funding, German pharma firms set a blistering pace in developing a shot against COVID-19. Therapeutic drugs against the disease , however, got left left behind. And it’s likely to stay that way.https://p.dw.com/p/3tbsrAdvertisement